A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial. (Q30317232)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial.
scientific article

    Statements

    title
    A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    25047747
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25047747%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    10 March 2020
    main subject
    chemotherapy
    0 references
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q30317232&oldid=1957650990"